Drug platforms
Fusion proteins consisting of an engineered IgG1 fragment and antigens could be used to clear disease-associated or imaging antibodies from circulation. The fusion protein consists of two parts: an Ig...
Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
Fusion proteins consisting of an engineered IgG1 fragment and antigens could be used to clear disease-associated or imaging antibodies from circulation. The fusion protein consists of two parts: an Ig...